Raoulic acid

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Raoulic acid (from the New Zealand plant, Raoulia australis) was found to possess strong antiviral activity against a number of Picornaviruses including human rhinovirus 2 (HRV2), human rhinovirus 3 (HRV3), coxsackie B3 (CB3), coxsackie B4 (CB4), and enterovirus 71 (EV71).[1]

References[edit | edit source]

  1. ↑ Choi, H.J.; Lim, C.H.; Song, J.H.; Baek, S.H.; Kwon, D.H. (January 2009), "Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses", Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 16 (1): 35–39, doi:10.1016/j.phymed.2008.10.012, ISSN 1618-095X, PMID 19097770

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

Retrieved from "https://me-pedia.org/w/index.php?title=Raoulic_acid&oldid=235975"